Inactive Instrument
Acticor Biotech SAS Stock Euronext Paris
Stocks
ALACT
FR0014005OJ5
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
CEO | Chief Executive Officer | - | 26/11/2013 |
Francois Guillet
DFI | Director of Finance/CFO | 68 | 13/10/2024 |
Anouar Sari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 26/11/2013 |
Alain Parthoens
BRD | Director/Board Member | 66 | 24/10/2018 |
Catherine Boule
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 12.69M | ||
| -1.39% | -6.15% | +56.05% | +71.53% | 54.49B | ||
| +3.13% | +11.16% | +67.30% | +94.35% | 55.93B | ||
| -0.80% | -6.47% | +5.95% | +426.55% | 23.87B | ||
| -0.02% | -3.76% | -18.65% | -16.04% | 22.86B | ||
| +3.51% | +7.50% | +47.81% | -3.33% | 20B | ||
| +1.94% | +0.21% | +39.31% | -29.41% | 17.48B | ||
| +10.00% | -2.06% | +210.10% | +370.99% | 15.39B | ||
| +7.69% | +4.38% | +56.51% | +712.88% | 15.19B | ||
| +0.15% | -0.75% | +26.40% | +190.20% | 14.02B | ||
| Average | +2.44% | +0.34% | +54.53% | +201.97% | 26.58B | |
| Weighted average by Cap. | +1.93% | +0.47% | +52.83% | +157.23% |
Employees
31
















